CAS 296280-56-3

Formula: C31H34N2O4

InChI: InChI=1S/C31H34N2O4/c1-22(34)32-16-14-26-8-3-6-24-10-12-28(20-30(24)26)36-18-5-19-37-29-13-11-25-7-4-9-27(31(25)21-29)15-17-33-23(2)35/h3-4,6-13,20-21H,5,14-19H2,1-2H3,(H,32,34)(H,33,35)

InChI key: NSXBZYDTTKLTOH-UHFFFAOYSA-N

SMILES: CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OCCCOC3=CC4=C(C=CC=C4CCNC(=O)C)C=C3

S26131

CAS: 296280-56-3

S26131

Formula: C₃₁H₃₄N₂O₄

Purity: ≥98%

Molecular weight: 498.61

Ref: 54-BUP10201

S26131

CAS: 296280-56-3

Formula: C₃₁H₃₄N₂O₄

Molecular weight: 498.6127

Ref: IN-DA01V1FK

S26131

CAS: 296280-56-3

S26131 (N-[2-[7-[3-[8-(2-acetamidoethyl)naphthalen-2-yl]oxypropoxy]naphthalen-1-yl]ethyl]acetamide) behaves as an antagonist on MT1 and MT2 receptors with Ki of

Formula: C₃₁H₃₄N₂O₄

Purity: 99.77%

Color and Shape: White Solid

Molecular weight: 498.6127

Ref: TM-T16834

S26131

CAS: 296280-56-3

S26131 is an advanced glycation end product (AGE) inhibitor, which is a synthetic compound designed for laboratory research purposes. It is derived from chemical synthesis processes, offering a robust tool for investigating the biochemical pathways associated with glycation. Its mechanism of action involves the inhibition of AGE formation, which is a post-translational modification resulting from the non-enzymatic reaction between sugars and proteins or lipids. This biochemical modulation is vital for studying the implications of glycation in various physiological and pathological contexts.

Formula: C₃₁H₃₄N₂O₄

Purity: Min. 95%

Molecular weight: 498.6 g/mol

Ref: 3D-WLA28056